Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus Type 18 Infection”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Not applicableActive Not RecruitingNCT05669911
What this trial is testing

Development of a Self-collection Device for Cervical Cancer Screening

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Human Papilloma Virus
Teal Health, Inc. 235
Testing effectiveness (Phase 2)Study completedNCT00339040
What this trial is testing

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 130
Post-approval studies (Phase 4)Looking for participantsNCT07668271
What this trial is testing

Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)

Who this might be right for
Infection by Human Papilloma Virus
Xiamen Innovax Biotech Co., Ltd 720
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Early research (Phase 1)Study completedNCT03813940
What this trial is testing

Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Condylomata AcuminataCervical Cancer
Xiamen University 24
Large-scale testing (Phase 3)Study completedNCT00834106
What this trial is testing

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC 3,006
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Large-scale testing (Phase 3)UnknownNCT06207175
What this trial is testing

Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 1,260
Testing effectiveness (Phase 2)Study completedNCT02740777
What this trial is testing

Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females

Who this might be right for
Human PapillomavirusCervical Intraepithelial NeoplasiaPersistent Infection
Shanghai Zerun Biotechnology Co.,Ltd 900
Large-scale testing (Phase 3)Active Not RecruitingNCT04537156
What this trial is testing

Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerCondylomata Acuminata
Xiamen University 9,327
Early research (Phase 1)Study completedNCT02405520
What this trial is testing

Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Who this might be right for
Condylomata Acuminata
Jun Zhang 145
Large-scale testing (Phase 3)Study completedNCT00128661
What this trial is testing

Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants

Who this might be right for
Cervical CancerPrecancerous Condition
GlaxoSmithKline 7,466
Not applicableEnded earlyNCT01355003
What this trial is testing

GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 1,080
Large-scale testing (Phase 3)Study completedNCT00325130
What this trial is testing

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 1,042
Not applicableStudy completedNCT01158209
What this trial is testing

An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt

Who this might be right for
Human Papillomavirus Infection
GlaxoSmithKline 490
Not applicableUnknownNCT04022148
What this trial is testing

The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years

Who this might be right for
Cancer of CervixVaccinia
University of Fukui 2,800
Large-scale testing (Phase 3)Study completedNCT02733068
What this trial is testing

A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Cervical Intraepithelial Neoplasia
Shanghai Zerun Biotechnology Co.,Ltd 12,000
Not applicableStudy completedNCT03206255
What this trial is testing

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 940
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07668960
What this trial is testing

Evaluation of the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of BBM-C101 Injection in Patients With Cervical High-Grade Squamous Intraepithelial Lesion(HSIL)

Who this might be right for
High-grade Squamous Intraepithelial Lesions of the Cervix Associated With Human Papillomavirus (HPV) Type 16 and/or HPV Type 18 Infection
Shanghai Mianyi Biopharmaceutical Co., Ltd. 60
Early research (Phase 1)Study completedNCT05680454
What this trial is testing

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 160
Next Page